Loading...

ADVM ADVERUM BIOTECHNOLOGIES INC Earnings Reports 8-K Filing

DVRM

DVM

ADVERUM BIOTECHNOLOGIES INC

(ADVM)

2025 8-K

Show Summary

Show Summary

Financial Statements

Financial Results

Financial Restatement

Positive Trial Results

Financial Results

Financial Results

Corporate Presentation and ...

Annual Meeting Results

Appointment and Resignation...

Financial Results Announcement

Reverse Stock Split

Financial Results Announcement

Corporate Presentation Upda...

Settlement Agreement for St...

Securities Purchase Agreement

Delisting Notice

Appointment of Dr. Nicholson

Financial Results Announcement

Appointment of Director

Earnings Reports

Appointment of CFO

Compliance regained with Na...

Annual Meeting of Stockholders

Management Change

Sales Agreement with Cowen ...

Earnings Reports

External Links:

On May 14, 2025, Adverum Biotechnologies, Inc. announced its financial results for the first quarter ended March 31, 2025, including a corporate update. The report is not deemed 'filed' under the Securities Exchange Act.

AI Assistant

ADVERUM BIOTECHNOLOGIES INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.